首页 » EGFRL858R-T790M-C797S NTCC® EGFR基因三突变细胞株 BioVector NTCC质粒载体菌株细胞蛋白抗体基因保藏中心

EGFRL858R-T790M-C797S NTCC® EGFR基因三突变细胞株 BioVector NTCC质粒载体菌株细胞蛋白抗体基因保藏中心

  • 价  格:¥998950
  • 货  号:NTCC® EGFRL858R-T790M-C797S
  • 产  地:北京
点击询问我要采购
 竭诚为您服务!
BioVector NTCC典型培养物保藏中心
联系人:Dr.Xu, Biovector NTCC Inc.

电话:400-800-2947 工作QQ:1843439339 (微信同号)

邮件:Biovector@163.com

手机:18901268599

地址:北京

已注册
 

EGFRL858R-T790M-C797S NTCC® EGFR基因三突变细胞株

BioVector NTCC质粒载体菌株细胞蛋白抗体基因保藏中心


NTCC® EGFRL858R-T790M-C797S cell line refers to a type of cancer cell line that carries specific mutations in the Epidermal Growth Factor Receptor (EGFR) gene.

  • EGFR: This gene encodes a protein that plays a crucial role in cell growth and survival. Mutations in EGFR can lead to uncontrolled cell growth and the development of cancer.

  • L858R, T790M, C797S: These are specific mutations within the EGFR gene:

    • L858R: An activating mutation that causes the EGFR protein to become constitutively active, promoting uncontrolled cell growth.

    • T790M: A resistance mutation that arises in response to treatment with first-generation EGFR tyrosine kinase inhibitors (TKIs).

    • C797S: A further resistance mutation that emerges in response to third-generation EGFR TKIs, which were developed to overcome the T790M resistance.


Significance of EGFRL858R-T790M-C797S cell lines:

  • Understanding Drug Resistance: These cell lines provide valuable models for studying the mechanisms of drug resistance in lung cancer, particularly the emergence of resistance to EGFR TKIs.

  • Drug Discovery: They can be used to screen and develop new drugs that can overcome these resistance mechanisms and effectively target cancers with these specific EGFR mutations.

  • Preclinical Research: These cell lines can be used in preclinical studies to evaluate the efficacy and safety of new treatment approaches, such as targeted therapies or immunotherapies.

Key Points:

  • EGFRL858R-T790M-C797S cell lines represent a significant challenge in the treatment of lung cancer.

  • Understanding the mechanisms of resistance driven by these mutations is crucial for developing more effective therapies.

  • Continued research using these cell lines is essential for improving the outcomes for patients with EGFR-mutant lung cancer.


Image

Investigating effect of EMI1 on activated EGFR L858R/T790M/C797S... |  Download Scientific Diagram

Overall view of the structure of EGFRL858R/T790M/C797S showed the ATP... |  Download Scientific Diagram

NIH-3T3 Cell Line - Advancing Fibroblast Studies and Applications of NIH-3T3

生产厂家Supplier:

BioVector NTCC质粒载体菌株细胞蛋白抗体基因保藏中心

E-mail:BioVector@163.com


http://www.biovector.net


您正在向 biovector.net  发送关于产品 EGFRL858R-T790M-C797S NTCC® EGFR基因三突变细胞株 BioVector NTCC质粒载体菌株细胞蛋白抗体基因保藏中心 的询问

点击“立即发送”后,我们将在1个工作日内与您取得联系。